Asset Details
Do you wish to reserve the book?
Mycobacterium decipiens Infection in Patient Receiving Anti–TNF-α Therapy, France, 2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mycobacterium decipiens Infection in Patient Receiving Anti–TNF-α Therapy, France, 2024
Do you wish to request the book?
Mycobacterium decipiens Infection in Patient Receiving Anti–TNF-α Therapy, France, 2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mycobacterium decipiens Infection in Patient Receiving Anti–TNF-α Therapy, France, 2024
2026
Overview
Mycobacterium decipiens is a newly identified species with high genomic similarity to M. tuberculosis. We report a cutaneous M. decipiens infection in a patient in France who had inflammatory bowel disease being treated with anti-tumor necrosis factor-α therapy. The infection was successfully treated with an oral antimicrobial regimen.
Subject
/ Humans
/ Inflammatory Bowel Diseases - drug therapy
/ Male
/ Mycobacterium - classification
/ Mycobacterium Infections, Nontuberculous - diagnosis
/ Mycobacterium Infections, Nontuberculous - drug therapy
/ Mycobacterium Infections, Nontuberculous - microbiology
/ Nontuberculous Mycobacteria - classification
